Back
Product specifications
  • Active Ingredient (INN)
    Lenalidomide
  • Manufacturer
    Lotus
  • Country of manufacture
    Taiwan
  • Form/Dose
    25 mg hard capsules №21 (3X7)
  • Concentration
  • Excipients
  • Manufacturing site GMP status
    EU GMP Netherlands, Certificate No: NL/H 23/2048167
  • US FDA establishment registration (FEI; registration is not an FDA approval)
    3002806661
  • API manufacturing site GMP status
    US FDA GMP, PMDA (Japan) GMP and CGMP Compliant
  • Additional GMP certification
    EU GMP NETHERLANDS, PMDA JAPAN, CGMP Certified
  • Therapeutic Area
    Oncology
  • Country of manufacture
  • Manufacturing site country
    Taiwan
  • Additional Information
No items found.

Prescription-only medicine. This information is intended for healthcare professionals and prospective business partners. It is not promotional material and is not intended for patients. For approved product information, consult the Georgian medicines register or contact us. To report a suspected side effect from a medicine supplied by Mermisi, please contact us.